Lv1
65 积分 2021-04-14 加入
A real-world pharmacovigilance study of dacomitinib based on FDA adverse event reporting system (FAERS) database
18小时前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
8个月前
已完结
FOLFOX regimen induced severe hypokalaemia with hypocalcaemia and hypomagnesaemia
8个月前
已关闭
FOLFOX regimen induced severe hypokalaemia with hypocalcaemia and hypomagnesaemia
8个月前
已关闭
Recurrent chromosomal rearrangements of ROS1, FRK and IL6 activating JAK/STAT pathway in inflammatory hepatocellular adenomas
8个月前
已完结
Discovery of a first-in-class protein degrader for the c-ros oncogene 1 (ROS1)
8个月前
已完结
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis
9个月前
已完结
Comprehensive Review of ROS1 Tyrosine Kinase Inhibitors-Classified by Structural Designs and Mutation Spectrum (Solvent Front Mutation [G2032R] and Central β-Sheet 6 [Cβ6] Mutation [L2086F])
9个月前
已完结
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
9个月前
已完结
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Randomized Clinical Trial
9个月前
已完结
皖公网安备34019202002308
